Cost-effectiveness of l -glutamine versus crizanlizumab for adults with sickle cell disease: model focused on reducing pain episode costs from Qatar's healthcare perspective.
- Resource Type
- Article
- Source
- SAGE Open Medicine; 5/6/2024, p1-11, 11p
- Subject
- Language
- ISSN
- 20503121